Table 1.
Characteristics of the survey respondents (n = 511).a
| Total, n (%) | Missing, n (%) | |
|---|---|---|
| Sex | ||
| Male | 358 (70.9) | 6 (1.17) |
| Female | 147 (29.1) | |
| Age | ||
| 25-34 | 171 (33.7) | 3 (0.59) |
| 35-44 | 174 (34.3) | |
| 45-54 | 95 (18.7) | |
| 55-64 | 56 (11.0) | |
| 65+ | 12 (2.36) | |
| Region of practice | ||
| Africa | 24 (4.70) | 12 (2.35) |
| Asia | 135 (26.4) | |
| Australia | 5 (0.98) | |
| Europe | 124 (24.3) | |
| Middle East | 28 (5.48) | |
| North America | 59 (11.5) | |
| South America | 124 (24.3) | |
| City population size | ||
| <100 000 | 39 (7.63) | 4 (0.78) |
| 100 000-500 000 | 105 (20.5) | |
| 500 000-1 000 000 | 95 (18.6) | |
| 1 000 000-2 000 000 | 81 (15.9) | |
| >2 000 000 | 187 (36.6) | |
| Specialty | ||
| Oral and Maxillofacial Surgery | 412 (81.6) | 6 (1.17) |
| Plastic and Reconstructive Surgery | 54 (10.7) | |
| ENT | 25 (4.95 | |
| Head and Neck Surgery | 4 (0.79) | |
| Orthopedics | 4 (0.79) | |
| Other | 6 (1.18) | |
| Previous virus outbreak | ||
| None | 321 (62.8) | 26 (5.09) |
| SARS | 23 (4.50) | |
| Swine Flu | 100 (19.6) | |
| Both | 41 (8.02) | |
| Positive test for COVID-19 | ||
| Yes | 6 (1.33) | 59 (11.5) |
| No | 446 (98.7) | |
| Performing elective CMF surgery | ||
| Yes | 57 (13.3) | 83 (16.2) |
| No | 371 (86.7) | |
| Adequate PPE provision | ||
| Yes | 191 (42.6) | 63 (12.3) |
| No | 257 (57.3) | |
| Impact on research activity | ||
| Increase in productivity | 38 (9.74) | 121 (23.7) |
| No change | 47 (12.1) | |
| Decrease in productivity | 101 (25.9) | |
| Complete stop | 73 (18.7) | |
| I do not engage in research | 131 (33.6) | |
| Are guidelines followed for patient management? | ||
| Yes | 427 (95.7) | 65 (12.7) |
| No | 19 (4.26) |
Abbreviations: CMF, craniomaxillofacial; COVID-19, COrona VIrus Disease-19; PPE, personal protective equipment.
a Percentages are based on the number of valid cases.